Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Chronic Myeloid Leukemia (CML)


PF-04449913 for Hematologic Malignancies (UW09021)
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies

Investigator: Vivian Oehler, M.D,;   Conditions: Hematologic Malignancies;    Status: Closed;   Study ID: NCT00953758

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (2645)
A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Investigator: Vivian Oehler, MD;   Conditions: Chronic Myeloid Leukemia;    Status: Closed;   Study ID: NCT01650805